{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:05:41Z","timestamp":1790366741487,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.07.006","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:30:19Z","timestamp":1783726219000},"page":"1965-1977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein(a) and atrial fibrillation: Meta-analysis of observational and mendelian randomization studies shows no clinically meaningful association"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2095-8134","authenticated-orcid":false,"given":"Md","family":"Fahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoud","family":"Eldawud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6597-4125","authenticated-orcid":false,"given":"Roy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asher","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina A.","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Budzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.07.006_bib1","first-page":"3925","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur\u00a0Heart J"},{"key":"10.1016\/j.jacl.2026.07.006_bib2","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.07.006_bib3","first-page":"76","article-title":"Lipoprotein (a): structure, pathophysiology and clinical implications","volume":"103","author":"Maranh\u00e3o","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1194\/jlr.R051904","article-title":"Lipoprotein (a): impact by ethnicity and environmental and medical conditions","volume":"57","author":"Enkhmaa","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.006_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2021.11.055","article-title":"Repeat measures of lipoprotein(a) molar concentration and cardiovascular risk","volume":"79","author":"Trinder","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib6","first-page":"748","article-title":"Prevalence of lipoprotein(a) measurement in patients with or at risk of cardiovascular disease","volume":"17","author":"Panza","year":"2023","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.006_bib7","article-title":"An update on lipoprotein (a): the latest on testing, treatment, and guideline recommendations","author":"Alebna","year":"2023","journal-title":"Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.atherosclerosis.2022.04.005","article-title":"Lipoprotein(a) and ethnicities","volume":"349","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.006_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jacc.2022.06.019","article-title":"Ancestry, lipoprotein(a), and cardiovascular risk thresholds","volume":"80","author":"Tsimikas","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2021.05.037","article-title":"Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease","volume":"78","author":"Schachtl-Riess","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12920-024-02024-0","article-title":"Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk","volume":"17","author":"Behera","year":"2023","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jacl.2026.07.006_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.04.003","article-title":"Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene","volume":"349","author":"Coassin","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.006_bib13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2026.07.006_bib14","first-page":"18316","article-title":"The prospective effect of lipoprotein(a) on new-onset atrial fibrillation in patients with chronic heart failure","volume":"9","author":"Li","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib15","article-title":"Prevalence of hyperlipoproteinemia(a) in individuals of European ancestry treated at outpatient cardiology clinics: results from a cross-sectional STAR-Lp(a) study","volume":"134","author":"Burzy\u0144ska","year":"2024","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/circ.150.suppl_1.4143355","article-title":"Abstract 4143355: association of elevated serum lipoprotein(a) with new-onset atrial fibrillation: a retrospective study of 108930 patients","volume":"150","author":"Kamel","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2026.07.006_bib17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jacc.2022.02.018","article-title":"Elevated lipoprotein(a) and risk of atrial fibrillation: an observational and Mendelian randomization study","volume":"79","author":"Mohammadi-Shemirani","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.003354","article-title":"Associations of genetically predicted Lp(a) (lipoprotein [a]) levels with cardiovascular traits in individuals of European and African Ancestry","volume":"14","author":"Satterfield","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib19","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1016\/j.hrthm.2025.08.001","article-title":"Lipoprotein(a) elevation independently associates with incident atrial fibrillation irrespective of inflammatory status","volume":"22","author":"Li","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacl.2026.07.006_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-024-02163-4","article-title":"Associations of lipids and lipid-modifying drug target genes with atrial fibrillation risk based on genomic data","volume":"23","author":"Tao","year":"2024","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.07.006_bib21","first-page":"11029","article-title":"Lipoprotein (a) as a cardiovascular risk factor in controversial clinical scenarios: a narrative review","volume":"25","author":"Abdalla","year":"2024","journal-title":"Int\u00a0J\u00a0Mol\u00a0Sci"},{"key":"10.1016\/j.jacl.2026.07.006_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/europace\/euac260","article-title":"Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods","volume":"25","author":"Toprak","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jacl.2026.07.006_bib23","first-page":"319","article-title":"Study on the correlation between red cell distribution width, homocysteine, lipoprotein(a), and left atrial diameter in newly diagnosed nonvalvular atrial fibrillation patients","author":"Zhang","year":"2024","journal-title":"Eur\u00a0Rev\u00a0Med\u00a0Pharmacol\u00a0Sci"},{"key":"10.1016\/j.jacl.2026.07.006_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1439013","article-title":"Trends and findings of lipoprotein(a) testing and associated cardiovascular disease profiles: a large single-center study from the Middle East-Gulf region","volume":"11","author":"Manla","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.120.002996","article-title":"Comprehensive investigation of circulating biomarkers and their causal role in atherosclerosis-related risk factors and clinical events","volume":"13","author":"Zanetti","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.numecd.2021.02.011","article-title":"Causal effects of plasma lipids on the risk of atrial fibrillation: a multivariable mendelian randomization study","volume":"31","author":"Jiang","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacl.2026.07.006_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/clc.24086","article-title":"The association between lipoprotein(a) and atrial fibrillation: a systemic review and meta-analysis","volume":"46","author":"Yang","year":"2023","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12944-022-01728-5","article-title":"Low lipoprotein(a) concentration is associated with atrial fibrillation: a large retrospective cohort study","volume":"21","author":"Tao","year":"2022","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.07.006_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.006_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2022.04.008","article-title":"Lipoprotein(a) measurement issues: are we making a mountain out of a molehill?","volume":"349","author":"Kronenberg","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.006_bib31","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacl.2026.07.006_bib32","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacl.2026.07.006_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12863-015-0211-2","article-title":"Assessing the quality of published genetic association studies in meta-analyses: the quality of genetic studies (Q-Genie) tool","volume":"16","author":"Sohani","year":"2015","journal-title":"BMC Genetics"},{"key":"10.1016\/j.jacl.2026.07.006_bib34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/eurjpc\/zwaf063","article-title":"Elevated lipoprotein(a) levels linked to new-onset atrial fibrillation: insights from a retrospective cohort study","volume":"32","author":"Awad","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib35","article-title":"Lipoprotein(a) and lipid profile in patients with atrial fibrillation","volume":"12","author":"D\u00edaz-Peromingo","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jacl.2026.07.006_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-5751-10-15","article-title":"Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion","volume":"10","author":"Naji","year":"2011","journal-title":"J Negat Results Biomed"},{"key":"10.1016\/j.jacl.2026.07.006_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007372","article-title":"Associations of lipoprotein(a) levels with incident atrial fibrillation and ischemic stroke: the ARIC (Atherosclerosis Risk in Communities) study","volume":"6","author":"Aronis","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2026.07.006_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/03000605221109387","article-title":"The effect of apolipoprotein E gene polymorphism and Lp(a) levels on coronary artery disease with atrial fibrillation","volume":"50","author":"Li","year":"2022","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jacl.2026.07.006_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s40001-022-00825-6","article-title":"The relationship between lipoprotein(a) and risk of cardiovascular disease: a Mendelian randomization analysis","volume":"27","author":"Wang","year":"2022","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jacl.2026.07.006_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031581","article-title":"The association between serum albumin levels and related metabolic factors and atrial fibrillation: a retrospective study","volume":"101","author":"Zhao","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacl.2026.07.006_bib41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","article-title":"Paradoxical association of lipoprotein measures with incident atrial fibrillation","volume":"7","author":"Mora","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.hrthm.2023.11.024","article-title":"Oxidized high-density lipoprotein associates with atrial fibrillation","volume":"21","author":"Pagonas","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacl.2026.07.006_bib43","article-title":"Clinical prediction study on the risk of atrial fibrillation in hypertensive patients based on metabolism, inflammation, and gender differences","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacl.2026.07.006_bib44","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/j.jacc.2023.10.016","article-title":"Association of lipoprotein(a) levels with myocardial fibrosis in the Multi-Ethnic Study of Atherosclerosis","volume":"82","author":"Chehab","year":"2023","journal-title":"JACC"},{"key":"10.1016\/j.jacl.2026.07.006_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.12997\/jla.2023.12.3.267","article-title":"Elevated lipoprotein(a) levels and atrial fibrillation: a systematic review","volume":"12","author":"Masson","year":"2023","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacl.2026.07.006_bib46","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2023.02.050","article-title":"Lipoprotein(a), oxidized phospholipids, and coronary artery disease severity and outcomes","volume":"81","author":"Gilliland","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.jacl.2026.07.006_bib48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4330\/wjc.v15.i5.229","article-title":"Atrial fibrillation and coronary artery disease: an integrative review focusing on therapeutic implications of this relationship","volume":"15","author":"Batta","year":"2023","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117439","article-title":"Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia","volume":"389","author":"Wodaje","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.006_bib50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1194\/jlr.R051870","article-title":"Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis","volume":"57","author":"Thanassoulis","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.006_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2021.11.029","article-title":"Elevated lipoprotein(a) in mitral and aortic valve calcification and disease: the Copenhagen General Population Study","volume":"349","author":"Kaltoft","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.006_bib53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccep.2020.11.002","article-title":"Implications of inflammation and fibrosis in atrial fibrillation pathophysiology","volume":"13","author":"Harada","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.jacl.2026.07.006_bib54","article-title":"Role of inflammation in the pathogenesis of atrial fibrillation","volume":"13\u00a02022","author":"Ihara","year":"2022","journal-title":"Front\u00a0Physiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","article-title":"Molecular basis of atrial fibrillation pathophysiology and therapy","volume":"127","author":"Nattel","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2026.07.006_bib56","article-title":"Association between lipoprotein (a) and risk of atrial fibrillation: a systematic review and meta-analysis of Mendelian randomization studies","volume":"49","author":"Singh","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib57","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.3390\/jcm14217770","article-title":"Lipoprotein(a) and atrial fibrillation: a systematic review and meta-analysis","volume":"14","author":"Maj","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib59","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease","volume":"387","author":"O\u2019Donoghue","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2025.03.019","article-title":"Design and rationale of Lp(a)HORIZON trial: assessing the effect of lipoprotein(a) lowering with pelacarsen on major cardiovascular events in patients with CVD and elevated Lp(a)","volume":"287","author":"Cho","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacl.2026.07.006_bib61","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/acr.25400","article-title":"A guide to understanding Mendelian randomization studies","volume":"76","author":"Nguyen","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jacl.2026.07.006_bib62","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2026.07.006_bib63","article-title":"Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: a systematic review and meta-analysis","volume":"98","author":"Li","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacl.2026.07.006_bib64","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/gepi.21998","article-title":"Bias due to participant overlap in two-sample Mendelian randomization","volume":"40","author":"Burgess","year":"2016","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib65","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41562-023-01579-9","article-title":"Participation bias in the UK Biobank distorts genetic associations and downstream analyses","volume":"7","author":"Schoeler","year":"2023","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.jacl.2026.07.006_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/ije\/dyac233","article-title":"An empirical investigation into the impact of winner\u2019s curse on estimates from Mendelian randomization","volume":"52","author":"Jiang","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacl.2026.07.006_bib67","article-title":"Navigating sample overlap, winner\u2019s curse and weak instrument bias in Mendelian randomization studies using the UK Biobank","author":"Sadreev","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.jacl.2026.07.006_bib68","first-page":"376","article-title":"A robust and efficient method for Mendelian randomization with hundreds of genetic variants","volume":"11","author":"Burgess","year":"2020","journal-title":"Nat\u00a0Commun"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287426004393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:57:16Z","timestamp":1790366236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287426004393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":68,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1933287426004393"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) and atrial fibrillation: Meta-analysis of observational and mendelian randomization studies shows no clinically meaningful association","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}